Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection

Acute otitis media (AOM) is a common complication of upper respiratory tract infection whose pathogenesis involves both viruses and bacteria. We examined risks of acute otitis media associated with specific combinations of respiratory viruses and acute otitis media bacterial pathogens. Data were fro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical microbiology Jg. 49; H. 11; S. 3750
Hauptverfasser: Pettigrew, Melinda M, Gent, Janneane F, Pyles, Richard B, Miller, Aaron L, Nokso-Koivisto, Johanna, Chonmaitree, Tasnee
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 01.11.2011
Schlagworte:
ISSN:1098-660X, 1098-660X
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Acute otitis media (AOM) is a common complication of upper respiratory tract infection whose pathogenesis involves both viruses and bacteria. We examined risks of acute otitis media associated with specific combinations of respiratory viruses and acute otitis media bacterial pathogens. Data were from a prospective study of children ages 6 to 36 months and included viral and bacterial culture and quantitative PCR for respiratory syncytial virus (RSV), human bocavirus, and human metapneumovirus. Repeated-measure logistic regression was used to assess the relationship between specific viruses, bacteria, and the risk of acute otitis media complicating upper respiratory tract infection. In unadjusted analyses of data from 194 children, adenovirus, bocavirus, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis were significantly associated with AOM (P < 0.05 by χ(2) test). Children with high respiratory syncytial virus loads (≥3.16 × 10(7) copies/ml) experienced increased acute otitis media risk. Higher viral loads of bocavirus and metapneumovirus were not significantly associated with acute otitis media. In adjusted models controlling for the presence of key viruses, bacteria, and acute otitis media risk factors, acute otitis media risk was independently associated with high RSV viral load with Streptococcus pneumoniae (odds ratio [OR], 4.40; 95% confidence interval [CI], 1.90 and 10.19) and Haemophilus influenzae (OR, 2.04; 95% CI, 1.38 and 3.02). The risk was higher for the presence of bocavirus and H. influenzae together (OR, 3.61; 95% CI, 1.90 and 6.86). Acute otitis media risk differs by the specific viruses and bacteria involved. Acute otitis media prevention efforts should consider methods for reducing infections caused by respiratory syncytial virus, bocavirus, and adenovirus in addition to acute otitis media bacterial pathogens.
AbstractList Acute otitis media (AOM) is a common complication of upper respiratory tract infection whose pathogenesis involves both viruses and bacteria. We examined risks of acute otitis media associated with specific combinations of respiratory viruses and acute otitis media bacterial pathogens. Data were from a prospective study of children ages 6 to 36 months and included viral and bacterial culture and quantitative PCR for respiratory syncytial virus (RSV), human bocavirus, and human metapneumovirus. Repeated-measure logistic regression was used to assess the relationship between specific viruses, bacteria, and the risk of acute otitis media complicating upper respiratory tract infection. In unadjusted analyses of data from 194 children, adenovirus, bocavirus, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis were significantly associated with AOM (P < 0.05 by χ(2) test). Children with high respiratory syncytial virus loads (≥3.16 × 10(7) copies/ml) experienced increased acute otitis media risk. Higher viral loads of bocavirus and metapneumovirus were not significantly associated with acute otitis media. In adjusted models controlling for the presence of key viruses, bacteria, and acute otitis media risk factors, acute otitis media risk was independently associated with high RSV viral load with Streptococcus pneumoniae (odds ratio [OR], 4.40; 95% confidence interval [CI], 1.90 and 10.19) and Haemophilus influenzae (OR, 2.04; 95% CI, 1.38 and 3.02). The risk was higher for the presence of bocavirus and H. influenzae together (OR, 3.61; 95% CI, 1.90 and 6.86). Acute otitis media risk differs by the specific viruses and bacteria involved. Acute otitis media prevention efforts should consider methods for reducing infections caused by respiratory syncytial virus, bocavirus, and adenovirus in addition to acute otitis media bacterial pathogens.
Acute otitis media (AOM) is a common complication of upper respiratory tract infection whose pathogenesis involves both viruses and bacteria. We examined risks of acute otitis media associated with specific combinations of respiratory viruses and acute otitis media bacterial pathogens. Data were from a prospective study of children ages 6 to 36 months and included viral and bacterial culture and quantitative PCR for respiratory syncytial virus (RSV), human bocavirus, and human metapneumovirus. Repeated-measure logistic regression was used to assess the relationship between specific viruses, bacteria, and the risk of acute otitis media complicating upper respiratory tract infection. In unadjusted analyses of data from 194 children, adenovirus, bocavirus, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis were significantly associated with AOM (P < 0.05 by χ(2) test). Children with high respiratory syncytial virus loads (≥3.16 × 10(7) copies/ml) experienced increased acute otitis media risk. Higher viral loads of bocavirus and metapneumovirus were not significantly associated with acute otitis media. In adjusted models controlling for the presence of key viruses, bacteria, and acute otitis media risk factors, acute otitis media risk was independently associated with high RSV viral load with Streptococcus pneumoniae (odds ratio [OR], 4.40; 95% confidence interval [CI], 1.90 and 10.19) and Haemophilus influenzae (OR, 2.04; 95% CI, 1.38 and 3.02). The risk was higher for the presence of bocavirus and H. influenzae together (OR, 3.61; 95% CI, 1.90 and 6.86). Acute otitis media risk differs by the specific viruses and bacteria involved. Acute otitis media prevention efforts should consider methods for reducing infections caused by respiratory syncytial virus, bocavirus, and adenovirus in addition to acute otitis media bacterial pathogens.Acute otitis media (AOM) is a common complication of upper respiratory tract infection whose pathogenesis involves both viruses and bacteria. We examined risks of acute otitis media associated with specific combinations of respiratory viruses and acute otitis media bacterial pathogens. Data were from a prospective study of children ages 6 to 36 months and included viral and bacterial culture and quantitative PCR for respiratory syncytial virus (RSV), human bocavirus, and human metapneumovirus. Repeated-measure logistic regression was used to assess the relationship between specific viruses, bacteria, and the risk of acute otitis media complicating upper respiratory tract infection. In unadjusted analyses of data from 194 children, adenovirus, bocavirus, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis were significantly associated with AOM (P < 0.05 by χ(2) test). Children with high respiratory syncytial virus loads (≥3.16 × 10(7) copies/ml) experienced increased acute otitis media risk. Higher viral loads of bocavirus and metapneumovirus were not significantly associated with acute otitis media. In adjusted models controlling for the presence of key viruses, bacteria, and acute otitis media risk factors, acute otitis media risk was independently associated with high RSV viral load with Streptococcus pneumoniae (odds ratio [OR], 4.40; 95% confidence interval [CI], 1.90 and 10.19) and Haemophilus influenzae (OR, 2.04; 95% CI, 1.38 and 3.02). The risk was higher for the presence of bocavirus and H. influenzae together (OR, 3.61; 95% CI, 1.90 and 6.86). Acute otitis media risk differs by the specific viruses and bacteria involved. Acute otitis media prevention efforts should consider methods for reducing infections caused by respiratory syncytial virus, bocavirus, and adenovirus in addition to acute otitis media bacterial pathogens.
Author Pettigrew, Melinda M
Chonmaitree, Tasnee
Gent, Janneane F
Miller, Aaron L
Nokso-Koivisto, Johanna
Pyles, Richard B
Author_xml – sequence: 1
  givenname: Melinda M
  surname: Pettigrew
  fullname: Pettigrew, Melinda M
  email: melinda.pettigrew@yale.edu
  organization: Yale School of Public Health, Yale School of Medicine, New Haven, CT 06520-8034, USA. melinda.pettigrew@yale.edu
– sequence: 2
  givenname: Janneane F
  surname: Gent
  fullname: Gent, Janneane F
– sequence: 3
  givenname: Richard B
  surname: Pyles
  fullname: Pyles, Richard B
– sequence: 4
  givenname: Aaron L
  surname: Miller
  fullname: Miller, Aaron L
– sequence: 5
  givenname: Johanna
  surname: Nokso-Koivisto
  fullname: Nokso-Koivisto, Johanna
– sequence: 6
  givenname: Tasnee
  surname: Chonmaitree
  fullname: Chonmaitree, Tasnee
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21900518$$D View this record in MEDLINE/PubMed
BookMark eNpN0D1PwzAQBmALFVFa2JiRN6YUn5sPe0QVnypiAcQWXZwzckmTYDtD_z0BisR070mvHuluxiZt1xJjZyAWAFJdPqweFwJA5QnAATsGoVWS5-Jt8i9P2SyEjRCQpll2xKYStBAZqGO2eXUem6RCE8k7bLhrxzBurmsDx7bm3oUP3lmOZojEu-iiC3xLtUNuum3fOIPRte986Hvy3FPoRzF2fsfjtzOCln64E3ZosQl0up9z9nJz_by6S9ZPt_erq3ViMpHHRFmDNWplCqugUtXSyrQmhXmB2bICRUYVwiBqKmogLYUhaStYatJ5YYHknF38ur3vPgcKsdy6YKhpsKVuCKUWkKdSi3Rsnu-bQzVeVPbebdHvyr_3yC95PGug
CitedBy_id crossref_primary_10_1007_s00430_013_0293_2
crossref_primary_10_1007_s40272_013_0044_2
crossref_primary_10_3389_fcimb_2014_00194
crossref_primary_10_1136_archdischild_2013_304681
crossref_primary_10_1093_cid_ciu303
crossref_primary_10_1128_JCM_01146_16
crossref_primary_10_1111_mmi_13698
crossref_primary_10_3389_fimmu_2018_02275
crossref_primary_10_1038_pr_2012_179
crossref_primary_10_1038_nrdp_2016_63
crossref_primary_10_1016_j_arr_2015_07_005
crossref_primary_10_1073_pnas_1603007113
crossref_primary_10_33667_2078_5631_2025_19_72_79
crossref_primary_10_1111_2049_632X_12216
crossref_primary_10_1128_JCM_00330_18
crossref_primary_10_1093_cid_ciu716
crossref_primary_10_1093_cid_ciae104
crossref_primary_10_1002_jmv_23455
crossref_primary_10_1128_IAI_01478_15
crossref_primary_10_22207_JPAM_16_2_66
crossref_primary_10_1002_lary_25762
crossref_primary_10_1371_journal_pone_0328651
crossref_primary_10_1093_cid_cix941
crossref_primary_10_1016_j_prrv_2012_04_002
crossref_primary_10_1093_cid_ciy750
crossref_primary_10_1128_mSphere_00286_18
crossref_primary_10_1016_j_anl_2024_01_002
crossref_primary_10_1097_INF_0b013e31827d104e
crossref_primary_10_1186_s40814_018_0337_x
crossref_primary_10_1016_j_vetmic_2016_03_020
crossref_primary_10_3389_fmicb_2024_1345027
crossref_primary_10_1097_INF_0000000000002256
crossref_primary_10_1371_journal_pone_0095160
crossref_primary_10_3389_fgene_2019_01230
crossref_primary_10_1155_2013_210490
crossref_primary_10_1177_014556131609500908
crossref_primary_10_1093_infdis_jit317
crossref_primary_10_3389_fmicb_2019_02412
crossref_primary_10_1007_s10096_013_1858_0
crossref_primary_10_1093_pch_21_1_39
crossref_primary_10_1007_s40136_017_0152_6
crossref_primary_10_1177_01455613211009151
crossref_primary_10_1002_jmv_27151
crossref_primary_10_1177_17534259221123309
crossref_primary_10_1016_j_vaccine_2019_03_013
crossref_primary_10_1164_rccm_201510_2000OC
crossref_primary_10_1134_S0006297916110110
crossref_primary_10_1177_11786361221104446
crossref_primary_10_1128_microbiolspec_GPP3_0004_2018
crossref_primary_10_1016_j_apr_2021_101198
crossref_primary_10_1016_j_mib_2016_11_003
crossref_primary_10_1038_s41522_024_00481_0
crossref_primary_10_1097_MOP_0000000000000184
crossref_primary_10_1586_ers_12_32
crossref_primary_10_1177_0194599816639028
crossref_primary_10_1007_s12105_021_01378_6
crossref_primary_10_1371_journal_pone_0170120
crossref_primary_10_1371_journal_ppat_1003057
crossref_primary_10_3390_cells11050916
crossref_primary_10_1097_INF_0000000000004939
crossref_primary_10_3389_fimmu_2017_01610
crossref_primary_10_1097_INF_0000000000000733
crossref_primary_10_3389_fcimb_2021_764772
crossref_primary_10_1097_INF_0000000000002486
crossref_primary_10_1002_ppul_24715
crossref_primary_10_1007_s15010_024_02305_x
crossref_primary_10_1016_j_jiac_2016_06_001
crossref_primary_10_1016_j_jcv_2015_06_005
crossref_primary_10_1016_j_jinf_2012_12_002
crossref_primary_10_1016_j_vaccine_2017_07_027
crossref_primary_10_1016_j_jinf_2017_04_003
crossref_primary_10_1177_0194599816643510
crossref_primary_10_1038_mi_2015_1
crossref_primary_10_1038_s41522_019_0105_6
crossref_primary_10_1002_1873_3468_13697
crossref_primary_10_1093_femsle_fnv062
crossref_primary_10_3390_microorganisms9061181
crossref_primary_10_1016_j_ijid_2022_02_040
crossref_primary_10_7759_cureus_64539
crossref_primary_10_1099_jmm_0_000810
crossref_primary_10_4103_1012_5574_133179
crossref_primary_10_1371_journal_ppat_1003709
crossref_primary_10_1186_1471_2431_12_87
crossref_primary_10_3389_fmicb_2023_1279159
crossref_primary_10_3390_children12040397
crossref_primary_10_1007_s11882_012_0303_2
crossref_primary_10_1111_irv_12174
crossref_primary_10_1128_Spectrum_01246_21
crossref_primary_10_1016_j_jpeds_2014_12_067
crossref_primary_10_1093_infdis_jiz193
crossref_primary_10_1097_INF_0000000000001412
crossref_primary_10_1016_j_vaccine_2013_03_024
crossref_primary_10_1542_peds_2015_3555
crossref_primary_10_1097_PCC_0000000000003017
crossref_primary_10_1128_IAI_00727_17
crossref_primary_10_1097_INF_0b013e31826f6144
crossref_primary_10_1097_INF_0b013e31827687fc
crossref_primary_10_1097_IM9_0000000000000081
crossref_primary_10_1128_AEM_01051_12
crossref_primary_10_1080_00325481_2015_1028872
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1128/JCM.01186-11
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1098-660X
ExternalDocumentID 21900518
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIDCD NIH HHS
  grantid: R01 DC005841
– fundername: NCRR NIH HHS
  grantid: UL1 RR029876
– fundername: NIAID NIH HHS
  grantid: R01 AI068043
– fundername: NCATS NIH HHS
  grantid: UL1 TR000071
– fundername: NIAID NIH HHS
  grantid: U54 AI057156
– fundername: NIAID NIH HHS
  grantid: AI057156
GroupedDBID ---
.55
.GJ
0R~
18M
29K
2WC
39C
3O-
4.4
41~
53G
5GY
5RE
5VS
AAGFI
ABOCM
ABPPZ
ACGFO
ADBBV
AENEX
AGCDD
AGVNZ
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
CGR
CS3
CUY
CVF
D-I
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FRP
GX1
H13
HF~
HYE
HZ~
H~9
KQ8
L7B
NPM
O9-
OHT
OK1
P2P
P6G
RHI
RNS
RPM
RSF
TR2
VH1
W8F
WHG
WOQ
X7M
ZCA
ZGI
ZXP
~KM
7X8
ID FETCH-LOGICAL-c506t-8fcada98c7f81b8b3f24de8a67a53b18ec870caa9e7d1e920ce2fb139e967f1e2
IEDL.DBID 7X8
ISICitedReferencesCount 114
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000296617300005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1098-660X
IngestDate Sun Nov 09 12:25:20 EST 2025
Mon Jul 21 06:06:07 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c506t-8fcada98c7f81b8b3f24de8a67a53b18ec870caa9e7d1e920ce2fb139e967f1e2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/3209086
PMID 21900518
PQID 901642904
PQPubID 23479
ParticipantIDs proquest_miscellaneous_901642904
pubmed_primary_21900518
PublicationCentury 2000
PublicationDate 2011-11-01
PublicationDateYYYYMMDD 2011-11-01
PublicationDate_xml – month: 11
  year: 2011
  text: 2011-11-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of clinical microbiology
PublicationTitleAlternate J Clin Microbiol
PublicationYear 2011
References 9598849 - South Med J. 1998 May;91(5):433-6
20508481 - Pediatr Infect Dis J. 2010 Jun;29(6):557-8
16989632 - Expert Rev Vaccines. 2006 Aug;5(4):517-34
15992930 - J Infect. 2006 Mar;52(3):181-7
20415535 - J Infect Dis. 2010 Jun 1;201(11):1625-32
18245415 - Pediatrics. 2008 Feb;121(2):253-60
18756188 - Pediatr Infect Dis J. 2008 Oct;27(10):897-902
12692096 - Clin Microbiol Rev. 2003 Apr;16(2):230-41
17156899 - Vaccine. 2007 Feb 19;25(9):1683-9
7844685 - J Pediatr. 1995 Feb;126(2):313-6
20185098 - Lancet Infect Dis. 2010 Mar;10(3):195-203
6281639 - N Engl J Med. 1982 Jun 10;306(23):1377-83
18258088 - Emerg Infect Dis. 2008 Jan;14(1):101-6
19153302 - Arch Otolaryngol Head Neck Surg. 2009 Jan;135(1):17-21
20955085 - J Infect Dis. 2010 Nov 15;202(10):1617; author reply 1618
19935445 - Pediatr Infect Dis J. 2010 Apr;29(4):304-9
17083014 - Clin Infect Dis. 2006 Dec 1;43(11):1417-22
20646956 - J Clin Virol. 2010 Aug;48(4):239-45
20113572 - Emerg Infect Dis. 2010 Feb;16(2):324-7
11385510 - Nat Med. 2001 Jun;7(6):719-24
17263836 - Clin Microbiol Infect. 2007 May;13(5):504-9
15999017 - Pediatr Infect Dis J. 2005 Jul;24(7):655-7
19221788 - Eur J Pediatr. 2009 Nov;168(11):1365-72
16388486 - J Infect Dis. 2006 Feb 1;193(3):387-95
20833582 - J Clin Virol. 2010 Nov;49(3):158-62
16967296 - Eur J Pediatr. 2007 Mar;166(3):223-8
18205533 - Clin Infect Dis. 2008 Feb 15;46(4):e34-7
20134359 - Pediatr Infect Dis J. 2010 Jun;29(6):540-5
19690308 - JAMA. 2009 Aug 19;302(7):758-66
16118271 - Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12891-6
15927278 - Antiviral Res. 2005 Aug;67(2):76-82
19843575 - J Leukoc Biol. 2010 Feb;87(2):213-22
20727478 - Diagn Microbiol Infect Dis. 2010 Sep;68(1):89-92
18279042 - Clin Infect Dis. 2008 Mar 15;46(6):815-23
17545372 - Pediatrics. 2007 Jun;119(6):1069-75
9920949 - N Engl J Med. 1999 Jan 28;340(4):260-4
16954253 - J Clin Microbiol. 2006 Sep;44(9):3231-5
References_xml – reference: 19935445 - Pediatr Infect Dis J. 2010 Apr;29(4):304-9
– reference: 12692096 - Clin Microbiol Rev. 2003 Apr;16(2):230-41
– reference: 20134359 - Pediatr Infect Dis J. 2010 Jun;29(6):540-5
– reference: 20727478 - Diagn Microbiol Infect Dis. 2010 Sep;68(1):89-92
– reference: 15992930 - J Infect. 2006 Mar;52(3):181-7
– reference: 17083014 - Clin Infect Dis. 2006 Dec 1;43(11):1417-22
– reference: 18245415 - Pediatrics. 2008 Feb;121(2):253-60
– reference: 11385510 - Nat Med. 2001 Jun;7(6):719-24
– reference: 16388486 - J Infect Dis. 2006 Feb 1;193(3):387-95
– reference: 19221788 - Eur J Pediatr. 2009 Nov;168(11):1365-72
– reference: 9920949 - N Engl J Med. 1999 Jan 28;340(4):260-4
– reference: 15999017 - Pediatr Infect Dis J. 2005 Jul;24(7):655-7
– reference: 16954253 - J Clin Microbiol. 2006 Sep;44(9):3231-5
– reference: 18205533 - Clin Infect Dis. 2008 Feb 15;46(4):e34-7
– reference: 16989632 - Expert Rev Vaccines. 2006 Aug;5(4):517-34
– reference: 20113572 - Emerg Infect Dis. 2010 Feb;16(2):324-7
– reference: 7844685 - J Pediatr. 1995 Feb;126(2):313-6
– reference: 16967296 - Eur J Pediatr. 2007 Mar;166(3):223-8
– reference: 17156899 - Vaccine. 2007 Feb 19;25(9):1683-9
– reference: 16118271 - Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12891-6
– reference: 17263836 - Clin Microbiol Infect. 2007 May;13(5):504-9
– reference: 20955085 - J Infect Dis. 2010 Nov 15;202(10):1617; author reply 1618
– reference: 20185098 - Lancet Infect Dis. 2010 Mar;10(3):195-203
– reference: 19690308 - JAMA. 2009 Aug 19;302(7):758-66
– reference: 20833582 - J Clin Virol. 2010 Nov;49(3):158-62
– reference: 18756188 - Pediatr Infect Dis J. 2008 Oct;27(10):897-902
– reference: 20508481 - Pediatr Infect Dis J. 2010 Jun;29(6):557-8
– reference: 20415535 - J Infect Dis. 2010 Jun 1;201(11):1625-32
– reference: 19153302 - Arch Otolaryngol Head Neck Surg. 2009 Jan;135(1):17-21
– reference: 15927278 - Antiviral Res. 2005 Aug;67(2):76-82
– reference: 18258088 - Emerg Infect Dis. 2008 Jan;14(1):101-6
– reference: 6281639 - N Engl J Med. 1982 Jun 10;306(23):1377-83
– reference: 9598849 - South Med J. 1998 May;91(5):433-6
– reference: 17545372 - Pediatrics. 2007 Jun;119(6):1069-75
– reference: 19843575 - J Leukoc Biol. 2010 Feb;87(2):213-22
– reference: 18279042 - Clin Infect Dis. 2008 Mar 15;46(6):815-23
– reference: 20646956 - J Clin Virol. 2010 Aug;48(4):239-45
SSID ssj0014455
Score 2.4022698
Snippet Acute otitis media (AOM) is a common complication of upper respiratory tract infection whose pathogenesis involves both viruses and bacteria. We examined risks...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 3750
SubjectTerms Child, Preschool
Cohort Studies
Comorbidity
Haemophilus influenzae - isolation & purification
Human bocavirus - isolation & purification
Humans
Infant
Metapneumovirus - isolation & purification
Microbial Interactions
Moraxella (Branhamella) catarrhalis - isolation & purification
Otitis Media - epidemiology
Otitis Media - microbiology
Otitis Media - virology
Polymerase Chain Reaction
Prospective Studies
Respiratory Syncytial Viruses - isolation & purification
Respiratory Tract Infections - complications
Respiratory Tract Infections - microbiology
Respiratory Tract Infections - virology
Risk Assessment
Streptococcus pneumoniae - isolation & purification
Title Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection
URI https://www.ncbi.nlm.nih.gov/pubmed/21900518
https://www.proquest.com/docview/901642904
Volume 49
WOSCitedRecordID wos000296617300005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwELWAAuLCUrayyQeuhjiLY58QqqgQolUPgHKLHGeMilASkhaJv8fOQk-IA5fcHEWT8eTF8-Y9hC5dKj3qB4r4LDU_KIwpwsEBopXDtRSMg6xFXB_DyYRHkZi23JyqpVV2NbEu1Gmu7Bn5tbBaUK5w_Jvig1jTKNtcbR00VlHPM0jGJnUYLZsIvl-bnlIrmcmYE3W8d5dfPwzHV3bmkhFKf8eW9TdmtPPPp9tF2y24xLdNNuyhFcj6aKOxm_zqo81x20jfR28vs1K-k6TRajZrrGxE2Qw5VFhmKbacc5xrLNViDtgy9mYVrudM8JKGnr3iRVFAictlxx7P7X1wx_LKDtDz6O5peE9a2wWiAofNCddKplJwFWqDaXniaddPgUsWysBLKAdl9riSUkCYUhCuo8DViYk_CBZqCu4hWsvyDI4RDiF0WaItZkp8RlkSCI9KJwAhNPMFHSDchTM2aW17FTKDfFHFPwEdoKPmlcRFI78RmxprSwk_-XvxKdqqz4Dr2cEz1NNmS8M5WlefJmblRZ0u5jqZjr8BtTLMLQ
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Viral-bacterial+interactions+and+risk+of+acute+otitis+media+complicating+upper+respiratory+tract+infection&rft.jtitle=Journal+of+clinical+microbiology&rft.au=Pettigrew%2C+Melinda+M&rft.au=Gent%2C+Janneane+F&rft.au=Pyles%2C+Richard+B&rft.au=Miller%2C+Aaron+L&rft.date=2011-11-01&rft.issn=1098-660X&rft.eissn=1098-660X&rft.volume=49&rft.issue=11&rft.spage=3750&rft_id=info:doi/10.1128%2FJCM.01186-11&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1098-660X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1098-660X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1098-660X&client=summon